Download presentation
Presentation is loading. Please wait.
Published by윤선 선우 Modified over 5 years ago
1
Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis R. Altman, M. Hochberg, A. Kivitz, A. Gibofsky, D. Solorio, C. Young Osteoarthritis and Cartilage Volume 24, Pages S419-S420 (April 2016) DOI: /j.joca Copyright © Terms and Conditions
2
Figure 1. Continuous responder analysis of the WOMAC pain subscale scores at week 12 in patients with osteoarthritis. Osteoarthritis and Cartilage , S419-S420DOI: ( /j.joca ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.